Calmodulin-dependent kinase II regulates osteoblast differentiation through regulation of Osterix

Biochemical and Biophysical Research Communications

Volumn 432, Issue 2, 2013, Pages 248-255

  Choi, You Hee ^a   Choi, Jun Ha ^b   Oh, Jae Wook ^b   Lee, Kwang Youl ^a  

^a Chonnam National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

Calmodulin dependent kinase II; Osteoblast differentiation; Osterix; Protein stability; Transcriptional activity

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; CALMODULIN DEPENDENT KINASE II; COLLAGEN TYPE 1; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PROTEIN KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR OSTERIX; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; BENZYLAMINES; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CELL DIFFERENTIATION; CELL LINE; HEK293 CELLS; HUMANS; MICE; OSTEOBLASTS; OSTEOGENESIS; PROTEIN KINASE INHIBITORS; SULFONAMIDES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84875232712     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.005     Document Type: Article

References (28)

1. Blum B., Moseley J., Miller L., Richelsoph K., Haggard W. Measurement of bone morphogenetic proteins and other growth factors in demineralized bone matrix. Orthopedics 2004, 27:s161-s165.
2. Yamaguchi A., Komori T., Suda T. Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr. Rev. 2000, 21:393-411.
3. Matsubara T., Kida K., Yamaguchi A., Hata K., Ichida F., Meguro H., Aburatani H., Nishimura R., Yoneda T. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation. J. Biol. Chem. 2008, 283:29119-29125.
4. Ulsamer A., Ortuno M.J., Ruiz S., Susperregui A.R., Osses N., Rosa J.L., Ventura F. BMP-2 induces Osterix expression through up-regulation of Dlx5 and its phosphorylation by p38. J. Biol. Chem. 2008, 283:3816-3826.
5. Lee M.H., Kwon T.G., Park H.S., Wozney J.M., Ryoo H.M. BMP-2-induced Osterix expression is mediated by Dlx5 but is independent of Runx2. Biochem. Biophys. Res. Commun. 2003, 309:689-694.
6. Heino T.J., Hentunen T.A. Differentiation of osteoblasts and osteocytes from mesenchymal stem cells. Curr. Stem Cell Res. Ther. 2008, 3:131-145.
7. Komori T. Regulation of osteoblast differentiation by transcription factors. J. Cell. Biochem. 2006, 99:1233-1239.
8. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
9. Bendall A.J., Abate-Shen C. Roles for Msx and Dlx homeoproteins in vertebrate development. Gene 2000, 247:17-31.
10. Hassan M.Q., Javed A., Morasso M.I., Karlin J., Montecino M., van Wijnen A.J., Stein G.S., Stein J.L., Lian J.B. Dlx3 transcriptional regulation of osteoblast differentiation: temporal recruitment of Msx2, Dlx3, and Dlx5 homeodomain proteins to chromatin of the osteocalcin gene. Mol. Cell. Biol. 2004, 24:9248-9261.
11. Kim Y.J., Kim H.N., Park E.K., Lee B.H., Ryoo H.M., Kim S.Y., Kim I.S., Stein J.L., Lian J.B., Stein G.S., van Wijnen A.J., Choi J.Y. The bone-related Zn finger transcription factor Osterix promotes proliferation of mesenchymal cells. Gene 2006, 366:145-151.
12. Hatta M., Yoshimura Y., Deyama Y., Fukamizu A., Suzuki K. Molecular characterization of the zinc finger transcription factor, Osterix. Int. J. Mol. Med. 2006, 17:425-430.
13. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002, 108:17-29.
14. Berridge M.J., Lipp P., Bootman M.D. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell. Biol. 2000, 1:11-21.
15. Zayzafoon M. Calcium/calmodulin signaling controls osteoblast growth and differentiation. J. Cell. Biochem. 2006, 97:56-70.
16. Zayzafoon M., Fulzele K., McDonald J.M. Calmodulin and calmodulin-dependent kinase IIalpha regulate osteoblast differentiation by controlling c-fos expression. J. Biol. Chem. 2005, 280:7049-7059.
17. Yuan K., Chung L.W., Siegal G.P., Zayzafoon M. Alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression. Lab. Invest. 2007, 87:938-950.
18. Quinn C.O., Rajakumar R.A., Agapova O.A. Parathyroid hormone induces rat interstitial collagenase mRNA through Ets-1 facilitated by cyclic AMP response element-binding protein and Ca(2+)/calmodulin-dependent protein kinase II in osteoblastic cells. J. Mol. Endocrinol. 2000, 25:73-84.
19. Anderson K.A., Noeldner P.K., Reece K., Wadzinski B.E., Means A.R. Regulation and function of the calcium/calmodulin-dependent protein kinase IV/protein serine/threonine phosphatase 2A signaling complex. J. Biol. Chem. 2004, 279:31708-31716.
20. Bowler W.B., Dixon C.J., Halleux C., Maier R., Bilbe G., Fraser W.D., Gallagher J.A., Hipskind R.A. Signaling in human osteoblasts by extracellular nucleotides. Their weak induction of the c-fos proto-oncogene via Ca2+ mobilization is strongly potentiated by a parathyroid hormone/cAMP-dependent protein kinase pathway independently of mitogen-activated protein kinase. J. Biol. Chem. 1999, 274:14315-14324.
21. Bergh J.J., Xu Y., Farach-Carson M.C. Osteoprotegerin expression and secretion are regulated by calcium influx through the L-type voltage-sensitive calcium channel. Endocrinology 2004, 145:426-436.
22. Ortuno M.J., Ruiz-Gaspa S., Rodriguez-Carballo E., Susperregui A.R., Bartrons R., Rosa J.L., Ventura F. P38 regulates expression of osteoblast-specific genes by phosphorylation of osterix. J. Biol. Chem. 2010, 285:31985-31994.
23. Choi Y.H., Jeong H.M., Jin Y.H., Li H., Yeo C.Y., Lee K.Y. Akt phosphorylates and regulates the osteogenic activity of Osterix. Biochem. Biophys. Res. Commun. 2011, 411:637-641.
24. Okamura H., Amorim B.R., Wang J., Yoshida K., Haneji T. Calcineurin regulates phosphorylation status of transcription factor osterix. Biochem. Biophys. Res. Commun. 2009, 379:440-444.
25. Bae D., Ceryak S. Raf-independent, PP2A-dependent MEK activation in response to ERK silencing. Biochem. Biophys. Res. Commun. 2009, 385:523-527.
26. Fukukawa C., Tanuma N., Okada T., Kikuchi K., Shima H. Pp 32/ I-1(PP2A) negatively regulates the Raf-1/MEK/ERK pathway. Cancer Lett. 2005, 226:155-160.
27. Li G., Ji X.D., Gao H., Zhao J.S., Xu J.F., Sun Z.J., Deng Y.Z., Shi S., Feng Y.X., Zhu Y.Q., Wang T., Li J.J., Xie D. EphB3 suppresses non-small-cell lung cancer metastasis via a PP2A/RACK1/Akt signalling complex. Nat. Commun. 2012, 3:667.
28. Hernandez F., Langa E., Cuadros R., Avila J., Villanueva N. Regulation of GSK3 isoforms by phosphatases PP1 and PP2A. Mol. Cell. Biochem. 2010, 344:211-215.